GRObio CEO, Dan Mandell, interviews professor George Church about the Genomically Recoded Organisms (GRO) platform that Dan spun out of his lab, asks him what technologies he is working on...
Read More
Ryan Cross interviewed our CEO, Dan Mandell, PhD, about how the Company’s GRO platform expands the limited amino acid alphabet that nature uses to make proteins, and how our Series...
Read More
Biotech TV host Brad Loncar visited GRObio’s office in Cambridge and had a discussion with GRObio CEO Dan Mandell, PhD about the Company’s recent Series B financing. In the interview,...
Read More
James Waldron reported on how GRObio’s $60.3 million Series B financing allows the Company to acquire clinical efficacy for its lead program in chronic refractory gout, and how our approach...
Read More
Hannah Green interviewed our CEO, Dan Mandell, PhD, about how GRObio’s ProGly-NSAAs prevent immune reactions that render many therapies ineffective, and how resolving this critical limitation is key to advancing...
Read More
Frank Vinluan interviewed our CEO, Dan Mandell, PhD, on GRO Biosciences’ platform for engineering therapeutic proteins without the immune reactions that often impair safety and efficacy, and how the Company’s...
Read More
Proceeds to advance clinical development of lead program for gout, broaden the Company’s pipeline, and expand its genomically recoded organism platform BOSTON, July 19, 2024 – GRO Biosciences Inc. (“GRObio”),…
BOSTON, March 18, 2024 - GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics,...
Read More
LISTEN TO THE PODCAST In this episode, Biorasi CEO Chris O’Brien hosted scientist and entrepreneur Daniel J. Mandell, Ph.D. to discuss how his creativity and imagination led him on a...
Read More
Data represent promising new modalities for reversing autoimmune disease without immunosuppression and for eliminating anti-drug antibodies against immunogenic therapies BOSTON, September 27, 2023 - GRO Biosciences Inc. (“GRObio”), an emerging...
Read More
